Cargando…

Validation of the CALL score as a mortality prediction tool in a cohort of hospitalized COVID-19 patients in Chile

INTRODUCTION: The CALL score is a predictive tool for respiratory failure progression in COVID-19. Whether the CALL score is useful to predict short- and medium-term mortality in an unvaccinated population is unknown. MATERIALS AND METHODS: This is a prospective cohort study in unvaccinated inpatien...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanhueza, Matías, Barrera, Manuel, Pedemonte, Juan C., Rojas, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497978/
https://www.ncbi.nlm.nih.gov/pubmed/37711735
http://dx.doi.org/10.3389/fmed.2023.1164615
_version_ 1785105421514571776
author Sanhueza, Matías
Barrera, Manuel
Pedemonte, Juan C.
Rojas, Luis
author_facet Sanhueza, Matías
Barrera, Manuel
Pedemonte, Juan C.
Rojas, Luis
author_sort Sanhueza, Matías
collection PubMed
description INTRODUCTION: The CALL score is a predictive tool for respiratory failure progression in COVID-19. Whether the CALL score is useful to predict short- and medium-term mortality in an unvaccinated population is unknown. MATERIALS AND METHODS: This is a prospective cohort study in unvaccinated inpatients with a COVID-19 pneumonia diagnosis upon hospital admission. Patients were followed up for mortality at 28 days, 3, 6, and 12 months. Associations between CALL score and mortality were analyzed using logistic regression. The prediction performance was evaluated using the area under a receiver operating characteristic curve (AUROC). RESULTS: A total of 592 patients were included. On average, the CALL score was 9.25 (±2). Higher CALL scores were associated with increased mortality at 28 days [univariate: odds ratio (OR) 1.58 (95% CI, 1.34–1.88), p < 0.001; multivariate: OR 1.54 (95% CI, 1.26–1.87), p < 0.001] and 12 months [univariate OR 1.63 (95% CI, 1.38–1.93), p < 0.001; multivariate OR 1.63 (95% CI, 1.35–1.97), p < 0.001]. The prediction performance was good for both univariate [AUROC 0.739 (0.687–0.791) at 28 days and 0.869 (0.828–0.91) at 12 months] and multivariate models [AUROC 0.752 (0.704–0.8) at 28 days and 0.862 (0.82–0.905) at 12 months]. CONCLUSION: The CALL score exhibits a good predictive capacity for short- and medium-term mortality in an unvaccinated population.
format Online
Article
Text
id pubmed-10497978
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104979782023-09-14 Validation of the CALL score as a mortality prediction tool in a cohort of hospitalized COVID-19 patients in Chile Sanhueza, Matías Barrera, Manuel Pedemonte, Juan C. Rojas, Luis Front Med (Lausanne) Medicine INTRODUCTION: The CALL score is a predictive tool for respiratory failure progression in COVID-19. Whether the CALL score is useful to predict short- and medium-term mortality in an unvaccinated population is unknown. MATERIALS AND METHODS: This is a prospective cohort study in unvaccinated inpatients with a COVID-19 pneumonia diagnosis upon hospital admission. Patients were followed up for mortality at 28 days, 3, 6, and 12 months. Associations between CALL score and mortality were analyzed using logistic regression. The prediction performance was evaluated using the area under a receiver operating characteristic curve (AUROC). RESULTS: A total of 592 patients were included. On average, the CALL score was 9.25 (±2). Higher CALL scores were associated with increased mortality at 28 days [univariate: odds ratio (OR) 1.58 (95% CI, 1.34–1.88), p < 0.001; multivariate: OR 1.54 (95% CI, 1.26–1.87), p < 0.001] and 12 months [univariate OR 1.63 (95% CI, 1.38–1.93), p < 0.001; multivariate OR 1.63 (95% CI, 1.35–1.97), p < 0.001]. The prediction performance was good for both univariate [AUROC 0.739 (0.687–0.791) at 28 days and 0.869 (0.828–0.91) at 12 months] and multivariate models [AUROC 0.752 (0.704–0.8) at 28 days and 0.862 (0.82–0.905) at 12 months]. CONCLUSION: The CALL score exhibits a good predictive capacity for short- and medium-term mortality in an unvaccinated population. Frontiers Media S.A. 2023-08-28 /pmc/articles/PMC10497978/ /pubmed/37711735 http://dx.doi.org/10.3389/fmed.2023.1164615 Text en Copyright © 2023 Sanhueza, Barrera, Pedemonte and Rojas. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Sanhueza, Matías
Barrera, Manuel
Pedemonte, Juan C.
Rojas, Luis
Validation of the CALL score as a mortality prediction tool in a cohort of hospitalized COVID-19 patients in Chile
title Validation of the CALL score as a mortality prediction tool in a cohort of hospitalized COVID-19 patients in Chile
title_full Validation of the CALL score as a mortality prediction tool in a cohort of hospitalized COVID-19 patients in Chile
title_fullStr Validation of the CALL score as a mortality prediction tool in a cohort of hospitalized COVID-19 patients in Chile
title_full_unstemmed Validation of the CALL score as a mortality prediction tool in a cohort of hospitalized COVID-19 patients in Chile
title_short Validation of the CALL score as a mortality prediction tool in a cohort of hospitalized COVID-19 patients in Chile
title_sort validation of the call score as a mortality prediction tool in a cohort of hospitalized covid-19 patients in chile
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497978/
https://www.ncbi.nlm.nih.gov/pubmed/37711735
http://dx.doi.org/10.3389/fmed.2023.1164615
work_keys_str_mv AT sanhuezamatias validationofthecallscoreasamortalitypredictiontoolinacohortofhospitalizedcovid19patientsinchile
AT barreramanuel validationofthecallscoreasamortalitypredictiontoolinacohortofhospitalizedcovid19patientsinchile
AT pedemontejuanc validationofthecallscoreasamortalitypredictiontoolinacohortofhospitalizedcovid19patientsinchile
AT rojasluis validationofthecallscoreasamortalitypredictiontoolinacohortofhospitalizedcovid19patientsinchile